期刊文献+

奥维加与临床常用输液的配伍稳定性研究 被引量:2

Study on the Compatible Stability of Lansoprazole for Injection and Clinical Commonly-Encountered Transfusion
下载PDF
导出
摘要 目的探讨奥维加与临床常用输液的配伍稳定性。方法选择国产注射用兰索拉唑(奥维加)与进口注射用兰索拉唑(进口品),按照说明书中配制方法溶解2种药品,并分别加人到100mL生理盐水注射液中,观察不同供试品在室温条件下放置0、2、4、6、8h的含量、pH、颜色、澄清度及不溶性微粒的变化。结果配伍后,在观察时间内奥维加与进口品溶液的含量均有普遍下降的趋势,溶液pH值均随时间的变化而普遍呈线性下降趋势,奥维加和进口品两组间比较差异无统计学意义(P〉0.05);配伍后,进口品溶液中10μm不溶性微粒数为755.60~9911.10粒,奥维加溶液中10μm不溶性微粒数为520.00~1988.90粒;进口品溶液中25μm不溶性微粒数为33.30~555.60粒,奥维加溶液中25μm不溶性微粒数为0~111.10粒,奥维加和进口品两组间比较差异有统计学意义(P〈o.05);奥维加与进口品溶液中的兰索拉唑在配伍后一段时间内,颜色均未发生变化,均保持澄清。结论在室温条件下将兰索拉唑溶于100mI。生理盐水注射液中,在含量、pH值、溶液颜色、溶液澄清度等方面奥维加与进口品等同,在不溶性微粒(10μm和25μm)方面优于进口品。 Objective To explore the compatible stability of Lansoprazole for injection and clinical commonly- encountered transfusion. Methods Domestic and imported Lansoprazole for injections were selected. According to the prepared methods in specification,two kinds of drugs were dissolved and put into 100 mL normal saline injection to observe the changes of contents, pH value, color, clarity and insoluble particles in different lansoprazole test solutions at 0, 2,4,6 and 8 h under room temperature. Results The lansoprazole contents in Lansoprazole for injection and imported product generally had the tendency of decrease within the observation time,and pH value of solution was on a declining curve with time. There was no significant difference between Lansoprazole for injection and imported product (P〉0. 05). After compatibility, the number of 10μm insoluble particles in the imported product was 755.60-9 911.10,while that in Lansoprazole for injection was 520.00-1 988. 90;the number of 25μm insoluble particles in the imported product was 33.30-555.60, while that in Lansoprazole for injection was 0-111.10, and statistical significance was presented between Lansoprazole for injection and imported product (P〈 0. 05). Lansoprazole contents in Lansoprazole for injection and imported product still remained clear,with no color changing after compatibility for a while. Conclusion Lansoprazole for injection,equal to the imported product in the aspects of content,pH value, solution color and clarity, is superior to the imported product in terms of insoluble particles (10μm and 25 μm) when lansoprazole is dissolved into 100 mL normal saline injection under room temperature.
出处 《成都医学院学报》 CAS 2013年第5期563-566,共4页 Journal of Chengdu Medical College
关键词 配伍 稳定性 兰索拉唑 生理盐水注射液 Compatibility Stability Lansoprazole Normal Saline Injection
  • 相关文献

参考文献10

  • 1李明杰,高菲菲,宋良伟,李晓峰,朱玉青.注射用兰索拉唑的杂质分析及稳定性研究[J].中国药房,2013,24(9):824-827. 被引量:5
  • 2杨应霓,余海宣,李庆南,罗梓河.兰索拉唑及其片剂的稳定性研究[J].中国现代应用药学,2003,20(3):203-205. 被引量:9
  • 3杨艳,李冰,孙英华,方金玲,何仲贵.注射用兰索拉唑与常用输液的配伍稳定性[J].中国新药杂志,2007,16(10):794-796. 被引量:20
  • 4Lu Y,Guo T, Qi J, et al. Enhanced Dissolution and Stability of Lansoprazole by Cyelodextrin Inclusion Complexation: Preparation, Characterization, and Molecular Modeling [J ]. AAPS PharmSciTech,2012,13(4) : 1222-1229.
  • 5Morrison JT, Logo RA, Thigpen JC, et al. Stability of Extemporaneously Prepared Lansoprazole Suspension at Two Temperatures[J]. The Journal of Pediatric Pharmacology and Therapeutics,2013,18(2) : 122-127.
  • 6Ding Y,Jia Y, Song Y, et al. The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects[J]. Eur J Clin Pharmacol, 2013, [Epub ahead of orint].
  • 7罗川萍,陈立虹,黄小琴,赵昕.碱性物质对兰索拉唑片稳定性的影响[J].中国药业,2013,22(15):42-43. 被引量:5
  • 8DiCiacinto Jise KM, Bergman KL, et al. Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes [J ]. Ann Pharmaeother,2000,34(5) : 600-605.
  • 9王东风,冯良,胡雪飞.奥美拉唑少见的严重不良反应[J].中国药师,2002,5(12):750-751. 被引量:13
  • 10Melkoumov A, Soukrati A, Elkin I,et al. Quality evaluation of extemporaneous delayed-release liquid formulations of lansoprazole[J]. Am J Health Syst Pharm, 2011,68 ( 21 ) 2069 -2074.

二级参考文献26

共引文献46

同被引文献15

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部